Message Font: Serif | Sans-Serif
 
UnThreaded | Threaded | Whole Thread (3) | Ignore Thread Prev | Next
Author: sheila727 Big gold star, 5000 posts Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 24974  
Subject: Re: The end of biotech? Date: 4/2/2014 11:54 AM
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Recommendations: 1
BMY's nivolumab & MRK's MK-3475 for melanoma


These two biologics disrupt the same immune-initiated apoptosis-inhibiting mechanism that contributes significantly to metastatic melanoma's resistance to treatment. One targets the receptor PD1, and the other targets its ligand PDL1.

It's important to realize that the potential goes well beyond metastatic melanoma. Although melanoma is currently showing the most dramatic results and so is getting the big press, two other treatment refractory cancers are also showing exciting results in clinical trials -- metastatic renal cell carcinoma and non-small cell lung cancer. Other advanced treatment-refractory cancers that are also in trials now include pancreatic cancer, small-cell lung cancer, triple-negative breast cancer, and stomach cancer.

This comment from a meeting in May 2013 expresses the general view: "This class of drugs is probably the most exciting thing in oncology, based on unprecedented results across several tumor types."

=sheila
Post New | Post Reply | Reply Later | Create Poll . Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (3) | Ignore Thread Prev | Next

Announcements

Pencils of Promise - Back to School Drive
"Pencils of Promise works with communities across the globe to build schools and create programs that provide education opportunities for children."
Managing Your Wealth
Our own TMFHockeypop from Rule Your Retirement fame on the TV show Managing Your Wealth.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Post of the Day:
Apple

The Saddest Place on iPhone Day
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement